Bladder Cancer

"Michael Droller has corralled the subjects' most influential opinion leaders and wrought from each a disciplined manuscript on their particular area of interest...it forms and excellent overview of Bladder Cancer for any urologist, senior urology resident or even the translational research investigator. As the chapters unroll, the organized structure of the compiled works progressively build the reader's knowledge...Dr. Droller skillfully used his editorial hand to maintain a disciplined text presenting scientific data to support any and all authored suppositions...Overall, I thoroughly enjoyed this text. I think even the reader well verse in the bladder cancer literature will benefit from the organized manner in which this text presents an enormous amount of information" - Journal of Pelvic Surgery "Dr. Droller has put together a small but densely packed volume on the current issues involved in managing patients with this disease. These issues include molecular markers of the disease, both for prognosis and detection, pathology, intravesical neoadjuvant and adjuvant chemotherapy, surgery, radiotherapy, urinary diversion techniques for both women and men and statistical consideration in bladder cancer trials. The authors of the chapters represent leaders in American universities as well as Norway and Sweden.- Oncology "This book presents a detailed summary of all aspects of bladder cancer and comprises contributions from 44 experts in this field...this text provides a precise synopsis of all contemporary issues in the management of bladder cancer. It would be useful as a reference to a busy urologist in practice and provides a well summarized, manageable text for those trainees sitting the Fellowship of the Royal College of Surgeons (Urology) examination." - British Journal of Surgery "Insightful and evidence-based, Bladder Cancer: Current Diagnosis and Treatment provides active clinicians and clinical investigators with not only a critical survey of the rapidly expanding research in the area, but also a state-of-the-art tutorial on today's optimal assessment and treatment of bladder cancer." -Tumori "The scope is ambitious and overall provides a very useful book for anyone using or about to use ELISAs...there is a lot of useful information not present in many other single ELISA publications..." - Immunology News "The book represents an outstanding work, completed by high quality figures and tables and it offers excellent and useful information for both urologists and clinical oncologists." - Neoplasma "...there are substantial chapters that focus on the epidemiology and the molecular biology of urothelial malignancy. This is timely - since, in common with other tumors, there has been a great deal of research in this area in recent years. Overall this is a useful book that summarizes modern thinking on the management of bladder cancer. It would be a useful addition to the collection of anyone involved in the management of this disease." - Cancer Forum

• 1 Demographic and Epidemiologic Aspects of Bladder Cancer.- 2 Biology and Molecular Aspects of Development and Progression of Bladder Cancer.- 3 Diagnosis of Bladder Cancer.- 4 Diagnostic Imaging in Urothelial Cancer.- 5 Urinary Cytology and its Role in Diagnosis and Monitoring of Urothelial Carcinoma.- 6 The Use of Tumor Markers in Bladder Cancer and Current Concepts on Clinical Applicability.- 7 Pathologic Assessment of Bladder Cancer and Pitfalls in Staging.- 8 Intravesical Chemotherapy in the Treatment of Superficial Bladder Cancer.- 9 Use of Intravesical BCG in Treatment of Superficial Bladder Cancer.- 10 Radical Cystectomy and Pelvic Lymphadenectomy in the Treatment of Infiltrative Bladder Cancer.- 11 Considerations in the Use of Neoadjuvant and Adjunctive Systemic Chemotherapy in Treatment of Invasive Bladder Cancer by Cystectomy.- 12 Clinical Situations for the Role of Radiation Therapy in the Treatment of Bladder Cancer.- 13 Current Concepts of Urinary Diversion in Men.- 14 Current Concepts of Urinary Diversion in Women.- 15 Current Prospects for the Use of Molecular Markers in Treatment of Bladder Cancer by Cystectomy or Bladder-Conserving Approaches.- 16 New Possibilities in Systemic Treatment for Metastatic Bladder Cancer.- 17 Statistical Considerations in the Phase II Evaluation of New Therapies.